Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Annexon Inc (ANNX)

Annexon Inc (ANNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Annexon Inc 1400 SIERRA POINT PARKWAY BLDG C SUITE 200 BRISBANE CA 94005 USA

www.annexonbio.com P: 650-822-5500 F: 650-636-9773

Description:

Annexon Inc. is a clinical-stage biopharmaceutical company. It engages in developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company's product candidate includes ANX005 and ANX007, which are in clinical stage. Annexon Inc. is based in SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 558,175
Enterprise Value, $K 333,065
Shares Outstanding, K 92,413
Annual Sales, $ 0 K
Annual Net Income, $ -134,240 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -25,180 K
EBIT, $ -131,050 K
EBITDA, $ -128,900 K
60-Month Beta 1.30
% of Insider Shareholders 12.67%
Float, K 80,704
% Float 87.33%
Short Volume Ratio 0.37

Growth:

1-Year Return 92.25%
3-Year Return -74.78%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 05/13/24
Next Earnings Date 08/05/24
Earnings Per Share ttm -1.47
EPS Growth vs. Prev Qtr 41.67%
EPS Growth vs. Prev Year 59.62%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ANNX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -56.52%
Return-on-Assets % -46.50%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.90
Book Value/Share 2.88
Interest Coverage -3.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar